Immunogenicity and Safety of Booster CYD-TDV Dengue Vaccine after Alternative Primary Vaccination Schedules in Healthy Individuals Aged 9–50 Years: a Randomised, Controlled, Phase 2, Non-Inferiority Study
Lancet Infectious diseases/The Lancet Infectious diseases（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined